It can regulate the Phosphatidylinositol 3-kinase (PI3K)/AKT pathway, improve insulin resistance, and activate downstream AKT, thereby promoting glucose transporter 2 (GLUT2) transport, and inhibiting glycogen synthase kinase-3 (GSK-3β) activities. The gene discussed is AKT1; the disease is Insulin resistance.